Mark Marino
Finanzdirektor/CFO bei RACKSPACE TECHNOLOGY, INC.
Vermögen: 200 510 $ am 30.04.2024
Profil
Mark A.
Marino is currently the Chief Financial Officer at Rackspace Technology, Inc. Prior to his current position, he served as the Vice President-Finance at Acelity LP, Inc. from 2015 to 2020 and at iHeartMedia, Inc. from 2012 to 2015.
Mr. Marino holds an MBA from Baylor University and an undergraduate degree from DePauw University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
18.04.2024 | 119 351 ( 0,05% ) | 200 510 $ | 30.04.2024 |
Aktive Positionen von Mark Marino
Unternehmen | Position | Beginn |
---|---|---|
RACKSPACE TECHNOLOGY, INC. | Finanzdirektor/CFO | 12.01.2024 |
Ehemalige bekannte Positionen von Mark Marino
Unternehmen | Position | Ende |
---|---|---|
Acelity LP, Inc.
Acelity LP, Inc. Medical/Nursing ServicesHealth Services Acelity LP, Inc. operates as a holding company, which engages in the research and development, manufacture, and marketing of regenerative medicines. The firm provides pressure wound therapy solutions and tissue matrices. It offers regenerative and reconstructive solutions to repair soft tissue defects and autologous fat grafting solutions. The company was founded in 1976 is headquartered in San Antonio, TX. | Finanzdirektor/CFO | 01.07.2020 |
IHEARTMEDIA, INC. | Corporate Officer/Principal | 01.03.2015 |
Ausbildung von Mark Marino
DePauw University | Undergraduate Degree |
Baylor University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
RACKSPACE TECHNOLOGY, INC. | Technology Services |
IHEARTMEDIA, INC. | Consumer Services |
Private Unternehmen | 1 |
---|---|
Acelity LP, Inc.
Acelity LP, Inc. Medical/Nursing ServicesHealth Services Acelity LP, Inc. operates as a holding company, which engages in the research and development, manufacture, and marketing of regenerative medicines. The firm provides pressure wound therapy solutions and tissue matrices. It offers regenerative and reconstructive solutions to repair soft tissue defects and autologous fat grafting solutions. The company was founded in 1976 is headquartered in San Antonio, TX. | Health Services |